HomeANRO • NYSE
Alto Neuroscience Inc
add
$2.25
0.88%
After Hours:(2.22%)-0.050
$2.20
Closed: Jun 20, 5:27:12 PM UTC-4 · USD · NYSE · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.68M | 8.97% |
Net income | -15.17M | -13.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -15.51M | -8.51% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 160.75M | -21.92% |
Total assets | 171.92M | -18.11% |
Total liabilities | 32.82M | 95.14% |
Total equity | 139.10M | — |
Shares outstanding | 27.07M | — |
Price to book | 0.44 | — |
Return on assets | -22.43% | — |
Return on capital | -23.47% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.17M | -13.06% |
Cash from operations | -16.56M | -50.74% |
Cash from investing | -24.00K | 89.29% |
Cash from financing | 9.13M | -93.22% |
Net change in cash | -7.48M | -106.06% |
Free cash flow | -12.47M | -130.68% |
Previous close
$2.27
Day range
$2.15 - $2.27
Year range
$1.60 - $17.55
Market cap
60.91M USD
Avg Volume
234.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
About
Founded
2019
Website
Employees
76
